The Air Liquide group firm is accelerating its investments in biotechnologies. Seppic has opened a laboratory devoted to fermentation on the group’s Innovation Campus Delaware, the place Seppic’s American Buyer Technical Service Heart has been primarily based since 2007.
Fermentation is a course of traditionally used to provide and protect meals. Utilized to the cosmetics and well being markets, this expertise allows the manufacturing of biobased substances with restricted impression on the setting and biodiversity, whereas minimizing impression on land use.
“With new gear and in depth know-how, the purpose of this laboratory will likely be to develop new substances that mix efficacy with a response to societal challenges within the cosmetics and well being fields, in keeping with the corporate’s method to dedicated innovation,” mentioned the corporate in a press release.
With this selection of location, Seppic goals to learn from robust synergies with Air Liquide Group R&D actions on the Campus, in addition to with the dynamic American Analysis ecosystem within the area of biotechnologies.
“Following the opening in 2024 of latest Analysis services at our Castres web site in France, Seppic continues to take a position sooner or later with this laboratory in america. It would allow us to proceed innovating for the efficiency of our substances by addressing the wants of our markets,” mentioned Hannes Moeller, Chief Govt Officer of Seppic.
